Author:
Zeng Zhaoyang,Bo Hao,Gong Zhaojian,Lian Yu,Li Xiayu,Li Xiaoling,Zhang Wenling,Deng Hao,Zhou Ming,Peng Shuping,Li Guiyuan,Xiong Wei
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
2. Wang M, Cao JX, Pan JH, Liu YS, Xu BL, et al. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer. PLoS One. 2014;9:e112662.
3. Zhang NN, Liu YT, Ma L, Wang L, Hao XZ, et al. The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy. PLoS One. 2014;9:e84501.
4. Aggarwal C. Targeted therapy for lung cancer: present and future. Ann Palliat Med. 2014;3:229–35.
5. Lu JY, Zhang M, Jin HL, Zhu JL, Wei JL, et al. Advances on molecular mechanism of chronic inflammation-driven lung cancer induced by environmental carcinogens. Prog Biochem Biophys. 2014;41:41–51.
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献